Cover Image
市場調查報告書

全球代謝體學市場:各國 (美國、加拿大、印度、中國、日本、英國) 、企業簡介、佔有率、趨勢、分析、機會、區分、預測 (2015年∼2021年)

Global Metabolomics Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 346122
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球代謝體學市場:各國 (美國、加拿大、印度、中國、日本、英國) 、企業簡介、佔有率、趨勢、分析、機會、區分、預測 (2015年∼2021年) Global Metabolomics Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日期: 2016年04月09日 內容資訊: 英文 140 Pages
簡介

代謝體學市場,由於對毒理學,營養基因學,功能基因學等,各種領域的技術引進增加,今後預期成長。北美佔最大的市場佔有率,接著是歐洲、亞太地區。

本報告提供全球代謝體學市場相關調查分析、市場概要、市場決策要素、各部門分析、市場區隔、競爭情形、各地區分析、企業簡介等系統性資訊。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 參數分析
  • 主要市場分析
  • R&D方案
  • 競爭資訊
  • 價值鏈分析
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題

第4章 各部門分析

  • 親市場分析
  • 競爭企業市場分析
  • 替代市場分析

第5章 市場區隔

  • 各使用技術
    • 分離
    • 電離
    • 檢測
    • 統計
  • 各應用
    • 農業
    • 生物標記
    • 個體化醫療
    • 毒理學
    • 功能基因學
    • 營養基因學

第6章 各地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 其他
  • 其他地區

第7章 企業簡介

  • Agilent technologies
  • Big medicine INC.
  • Biocrates Life Sciences
  • Bio-Rad laboratories
  • Bruker Corporation
  • Chenomx
  • Danaher Corporation
  • Human Metabolome Technologies, Inc.
  • LECO Corporation
  • Metabolon, Inc.
  • 島津製作所
  • Thermo Fisher Scientific Inc
  • OWL
  • TaKaRa BIO
  • Merck
  • Waters Corporation
  • Cinmet
  • Metasysx
  • Prometheus metabolomics ltd.
  • Ms-Omnics
  • Ingenuity systems
  • Metanomics heatlth
  • Molecular biometrics
  • Umetrics
  • Unilever

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HME-1591015

Metabolomics can be defined as the study of metabolites or low molecular weight molecules found inside the cells and the biological systems. This branch of science basically aims at the comparison finding out the differences between biological samples and is based on their metabolite profile. Metabolomics generally makes the use of analytical process like Chromatography, spectroscopy and multi variable analysis. The market of metabolomics is expected to increase in forecasted period due to increasing adoption of the technology to various fields such as toxicology, nutrigenomics, and Functional genomics. North America is having the largest share of market, Europe and Asia pacific follow It respectively.

The major driving factors of the market are the continuous research and development made in the field also the funding allotted by various government of different geographic regions, Rising popularity of personalized medicine and development in metabolite profiling is also contributing to its growth. It has got its application in several other lucrative industries such as agriculture, Biomarker discovery etc. Some of the challenges in the field are its complexity in holding and interpreting large amount of data, unavailability of complete metabolite libraries and lack of standardized people also adds to the challenges of the field.

The market of metabolomics is segmented on the basis of techniques used, and the various fields of application. Geographically the market is segmented into North America (US, Canada), Europe (UK, Italy, Spain, France, Germany, RoE), Asia-Pacific (India, Japan, Australia, China, Korea, RoAPAC) and Rest of World (Latin America, MENA and Africa). The key providers of metabolomics in the market include: Agilent technologies, Waters Corporation, Big medicine INC, Biocrates Life Sciences etc.

Companies Profiled include

  • 1. Agilent technologies
  • 2. Big medicine INC.
  • 3. Biocrates Life Sciences
  • 4. Bio-Rad laboratories
  • 5. Bruker Corporation
  • 6. Chenomx
  • 7. Danaher Corporation
  • 8. Human Metabolomics Technologies, Inc.
  • 9. LECO Corporation
  • 10. Metabolon, Inc.
  • 11. Shimadzu Corporation
  • 12. Thermo Fisher Scientific Inc
  • 13. Waters Corporation
  • 14. Ingenuity systems
  • 15. Metanomics heatlth
  • 16. Molecular biometrics
  • 17. Umetrics
  • 18. Unilever

This Occams Research Report covers

  • 1. Historical data
  • 2.Revenue forecasts, growth rates and CAGR upto 2022
  • 3.Industry Analysis
  • 4.Competitive Analysis
  • 5. Key geographic growth data

Table of Contents

1. Introduction

  • 1.1 Executive Summary
  • 1.2 Estimation methodology

2. Market overview

  • 2.1 Market definition and scope
  • 2.2 Key findings
  • 2.3 Parametric analysis
    • 2.3.1 Funding to the field by government
    • 2.3.2 R&D expenditure in the sector across geographies
    • 2.3.3 Use in various sectors
  • 2.4 Key market insights
    • 2.4.1 Top 3 emerging countries
    • 2.4.2 Top 3 revenue generating segments
    • 2.4.3 Market trends
    • 2.4.4 Winning strategy
    • 2.4.5 Pipeline analysis
  • 2.5 R & D Scenario
  • 2.6 Competitive intelligence
    • 2.6.1 Market share analysis
    • 2.6.2 Top winning strategies
    • 2.6.3 Case study; top competitive moves
  • 2.7 Value chain analysis
  • 2.8 Key buying criteria
  • 2.9 Strategic recommendation
  • 2.10 Strategic conclusion

3. Market determinants

  • 3.1 Market drivers
    • 3.1.1 Research and development going in the field
    • 3.1.2 Support of government
    • 3.1.3 Rising popularity of personalized medicine
    • 3.1.4 Use in sectors such as drug discovery and toxicology
  • 3.2 Market Restraints
    • 3.2.1 Low adoption rate
    • 3.2.2 Data complexity
    • 3.2.3 Shortage of skilled personal
  • 3.3 Market opportunities
    • 3.3.1 Proliferation of metabolomics laboratory management system
    • 3.3.2 Developments in metabolite profiling
    • 3.3.3 Biomarker discovery
  • 3.4 Market challenges
    • 3.4.1 unavailability of complete metabolite libraries
    • 3.4.2 Lack of standardized protocols

4. Sector analyses

  • 4.1 Parent market analysis
  • 4.2 Competitor market analysis
  • 4.3 Alternative market analysis

5 Market Segmentation

  • 5.1 Global metabolomics market on the basis of techniques used, 2014-2021, ($ millions)
    • 5.1.1 Global metabolomics market on the basis of Separation method, 2014-2021, ($ millions)
    • 5.1.2 Global metabolomics market on the basis of Ionization method, 2014-2021, ($ millions)
    • 5.1.3 Global metabolomics market on the basis of Detection method, 2014-2021, ($ millions)
    • 5.1.4 Global metabolomics market on the basis of Statistical methods, 2014-2021, ($ illions)
  • 5.2 Global metabolomics market on the basis of application, 2014-2021, ($ millions)
    • 5.2.1 Global metabolomics market on the basis of use in agriculture, 2014-2021, ($ millions)
    • 5.2.2 Global metabolomics market on the basis of use in Bio maker discover, 2014-2021, ($ illions)
    • 5.2.3 Global metabolomics market on the basis of use in personalized medicine, 2014-2021, $ millions)
    • 5.2.4 Global metabolomics market on the basis of use in toxicology, 2014-2021, ($ millions)
    • 5.2.5 Global metabolomics market on the basis of use in functional genomics, 2014-2021, ($ millions)
    • 5.2.6 Global metabolomics market on the basis of use in Nutrigenomics, 2014-2021, ($ millions)

6. Geographic analysis

  • 6.1 North America Metabolomics market, 2014-2021,($ millions)
    • 6.1.1 U.S Metabolomics market,2014-2021,($millions)
    • 6.1.2 Canada Metabolomics market,2014 -2021,($millions)
  • 6.2 Europe Metabolomics market,2014 -2021,($millions)
    • 6.2.1 U.K Metabolomics market,2014 -2021,($millions)
    • 6.2.2 Germany Metabolomics market,2014 -2021,($millions)
    • 6.2.3 France Metabolomics market,2014 -2021,($millions)
    • 6.1.1 Spain Metabolomics market,2014 -2021,($millions)
    • 6.1.2 Italy Metabolomics market,2014 -2021,($millions)
    • 6.1.3 others
  • 6.2 Asia Pacific
    • 6.2.1 China Metabolomics market ,2014 -2021,($millions)
    • 6.2.2 India Metabolomics market,2014 -2021,($millions)
    • 6.2.3 Korea Metabolomics market,2014 -2021,($millions)
    • 6.2.4 Japan Metabolomics market,2014 -2021,($millions)
    • 6.2.5 Australia Metabolomics market,2014 -2021,($millions)
    • 6.2.6 Rest of apac
  • 6.3 Rest of the world

7. Company Profiling

  • 7.1 Agilent technologies
  • 7.2 Big medicine INC.
  • 7.3 Biocrates Life Sciences
  • 7.4 Bio-Rad laboratories
  • 7.5 Bruker Corporation
  • 7.6 Chenomx
  • 7.7 Danaher Corporation
  • 7.8 Human Metabolome Technologies, Inc.
  • 7.9 LECO Corporation
  • 7.10 Metabolon, Inc.
  • 7.11 Shimadzu Corporation
  • 7.12 Thermo Fisher Scientific Inc
  • 7.13 OWL
  • 7.14 Takara bio
  • 7.15 Merck
  • 7.16 Waters Corporation
  • 7.17 Cinmet
  • 7.18 Metasysx
  • 7.19 Prometheus metabolomics ltd.
  • 7.20 Ms-Omnics
  • 7.21 Ingenuity systems
  • 7.22 Metanomics heatlth
  • 7.23 Molecular biometrics
  • 7.24 Umetrics
  • 7.25 Unilever
Back to Top